BRIEF published on 11/06/2024 at 07:35, 15 days 2 hours ago Sensorion participera aux principales conférences d'investisseurs en novembre 2024 Biotechnologie Conférences D'investisseurs Sensorion Thérapies Pour La Perte Auditive Développement De La Thérapie Génique
BRIEF published on 11/06/2024 at 07:35, 15 days 2 hours ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
PRESS RELEASE published on 11/06/2024 at 07:30, 15 days 2 hours ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs en novembre 2024. Découvrez les événements à venir et les programmes de thérapie de l'entreprise Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
PRESS RELEASE published on 11/06/2024 at 07:30, 15 days 2 hours ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
BRIEF published on 09/20/2024 at 07:35, 2 months 1 day ago Sensorion dévoile de nouvelles avancées cliniques prometteuses Biotechnologie Essais Cliniques Thérapie Génique Perte Auditive Petite Molécule
BRIEF published on 09/20/2024 at 07:35, 2 months 1 day ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 2 months 1 day ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 2 months 1 day ago Informations privilégiées / Autres communiqués Sensorion annonce de nouvelles données cliniques positives lors du Congrès Mondial d'Audiologie à Paris concernant les programmes de thérapie génique et de petite molécule Thérapie Génique Sensorion Données Cliniques Petite Molécule Congrès Mondial D'Audiologie
BRIEF published on 09/18/2024 at 07:35, 2 months 3 days ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
BRIEF published on 09/18/2024 at 07:35, 2 months 3 days ago Sensorion annonce ses résultats financiers et ses avancées cliniques pour le premier semestre 2024 Essais Cliniques Thérapie Génique Résultats Financiers 2024 Sensorion Thérapies Pour La Perte Auditive
Published on 11/21/2024 at 09:00, 58 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 23 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 33 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 58 minutes ago Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 58 minutes ago Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates
Published on 11/21/2024 at 09:41, 17 minutes ago Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 08:59, 58 minutes ago Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 58 minutes ago Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 43 minutes ago EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 06:58, 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 51 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 38 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
